ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

PALISADE CAPITAL MANAGEMENT, LP's Holding History (CIK: 0001009006)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 489,000 Value ($000) $460 Avg Close — Range —
Q4 2023
Shares 629,000 Value ($000) $620 Avg Close — Range —
Q3 2023
Shares 629,000 Value ($000) $582 Avg Close — Range —